Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials

Por Sjöstrand, Mikaela, Wei, Cheryl, Cook, William, Johnsson, Kristina, Pollack, Pia S., Stahre, Christina, Hirshberg, Boaz
Publicado no Diabetes Ther (2017)

Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin

Por Pollack, Pia S., Chadwick, Kristina D., Smith, David M., Billger, Martin, Hirshberg, Boaz, Iqbal, Nayyar, Boulton, David W.
Publicado no Cardiovasc Diabetol (2017)